RecruitingTotal Hip Arthroplasty (THA)HemiarthroplastyOsteoarthritis (OA) of the Hip
Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Primary Hip Prosthesis System
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is a multicenter, prospective, observational, post-market clinical follow-up (PMCF) study designed to evaluate the safety and clinical performance of the Tipmed™ Primary Hip Prosthesis System in adult subjects undergoing primary hip arthroplasty. The study aims to gather real-world clinical evidence on the 24-month post-operative safety profile, potential complications, and functional outcomes of the device during routine clinical practice.
Sponsor: TIPMED Medical Device Manufacturing Ltd. Co.
You may qualify if…
- ✓ Individuals aged 18 years and older,
- ✓ Male or female participants,
- ✓ Subjects who have undergone Primary Hip Arthroplasty (either total or partial) for any indication,
- ✓ Subjects in whose surgical procedure the Tipmed™ Primary Hip Prosthesis System components were utilized.
- ✓ Subjects who are not legally restricted (e.g., military personnel, convicts, or individuals under legal guardianship).
- ✓ Subjects who have voluntarily signed the written Informed Consent Form (ICF).
You may not qualify if…
- ✕ Subjects currently participating in any other interventional clinical trial.
Source: ClinicalTrials.gov · NCT07651735 · last updated 2026-06-16